Cargando…
Evaluation of efficacy and safety for bevacizumab in treating malignant pleural effusions caused by lung cancer through intrapleural injection
Some clinical investigations have assessed the efficacy and safety of bevacizumab combined with platinum anti-cancer drugs versus platinum drugs alone in treating malignant pleural effusion (MPE) caused by lung cancer through intrapleural injection. This report is a meta-analysis of independent rese...
Autores principales: | Zongwen, Sun, Song, Kong, Cong, Zhao, Tian, Fu, Yan, Zhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768330/ https://www.ncbi.nlm.nih.gov/pubmed/29371913 http://dx.doi.org/10.18632/oncotarget.22966 |
Ejemplares similares
-
Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion
por: He, Dongyun, et al.
Publicado: (2022) -
Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion
por: Moon, Youngkyu, et al.
Publicado: (2015) -
Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
por: Song, Xinyu, et al.
Publicado: (2018) -
Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion
por: Li, Xinying, et al.
Publicado: (2021) -
Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion
por: Kadhem, Husain, et al.
Publicado: (2021)